1.The value of prophylactic cranial irradiation in limited-stage small cell lung cancer: should it always be recommended?
Minji KOH ; Si Yeol SONG ; Ji Hwan JO ; Geumju PARK ; Jae Won PARK ; Su Ssan KIM ; Eun Kyung CHOI
Radiation Oncology Journal 2019;37(3):156-165
PURPOSE: Prophylactic cranial irradiation (PCI) is a standard treatment for limited-stage small cell lung cancer (LS-SCLC) showing a response to initial treatment, but many patients do not receive PCI due to comorbidities or refusal. This study aims to define the patient group for whom PCI can be omitted with minimal risk. MATERIALS AND METHODS: Patients with LS-SCLC who underwent radiotherapy with curative aim at our institution between January 2004 and December 2015 were retrospectively reviewed. Patients who did not receive PCI were evaluated for brain metastasis-free survival (BMFS), progression-free survival (PFS), overall survival (OS), and prognostic factors for survival, and treatment outcomes were compared with a patient cohort who received PCI. RESULTS: A total of 350 patients achieved a response following thoracic radiotherapy, and 190 of these patients did not receive PCI. Stage I–II and a complete response (CR) to initial therapy were good prognostic factors for BMFS and OS on univariate analysis. Patients with both stage I–II and a CR who declined PCI showed comparable 2-year BMFS to those who received PCI (92% vs. 89%). In patients who achieved CR, PCI did not significantly improve OS or PFS. CONCLUSION: There should be less concern about omitting PCI in patients with comorbidities if they have stage I–II or a CR, with brain metastasis control being comparable to those patients who receive PCI.
Brain
;
Cohort Studies
;
Comorbidity
;
Cranial Irradiation
;
Disease-Free Survival
;
Humans
;
Neoplasm Metastasis
;
Radiotherapy
;
Retrospective Studies
;
Small Cell Lung Carcinoma
2.Radiologic Features and Surgical Outcome of Juxtafacet Cyst Associated with Degenerative Lumbar Disease.
Whoan Jeang KIM ; Shann Haw CHANG ; Hwa Yeol YANG ; Won Jo KWON ; Hwan Il SUNG ; Kyung Hoon PARK ; Won Sik CHOY
The Journal of the Korean Orthopaedic Association 2017;52(1):65-72
PURPOSE: The purpose of this study was to evaluate the radiologic features of juxtafacet cyst and determine the correlation between these features and clinical outcome. MATERIALS AND METHODS: We analyzed a total of 23 patients. The degree of facet joint degeneration was classified using the Fujiwara method. The facet joint angles were measured with an magnetic resonance imaging to determine whether there was a difference between the cystic lesion that was occupied and the cystic lesion that was not occupied. Disc degeneration was measured by the Pfirrmann classification method. The clinical result was evaluated using the Oswestry disability index score and visual analogue scale. RESULTS: The L4–5 level of juxtafacet cyst was mostly affected, as found in previous studies. Facet joint arthritis was more severe within the side with the cystic lesion. Significant correlation was found between disc degeneration and juxtafacet joint cyst. All patients underwent wide decompression and fusion. Clinical result was excellent. No patients had signs of recurrence during the follow-up periods. CONCLUSION: Juxtafacet cyst has a significant correlation with facet joint degeneration. Therefore, aggressive surgical treatment—not just simple cyst excision—should be considered as the treatment option for juxtafacet cyst associated with degenerative lumbar disease.
Arthritis
;
Classification
;
Decompression
;
Follow-Up Studies
;
Humans
;
Intervertebral Disc Degeneration
;
Joints
;
Magnetic Resonance Imaging
;
Methods
;
Recurrence
;
Zygapophyseal Joint
3.Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer.
Tae Yeon LEE ; Yi Jo JEUNG ; Chun Jun LEE ; Heung Yeol KIM ; Sung Han KIM ; Won Gyu KIM
Obstetrics & Gynecology Science 2013;56(1):15-21
OBJECTIVE: The aim of this retrospective study is to evaluate the efficacy of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage IB cervical cancer. METHODS: From January 1993 to December 2007, a total of 100 patients of stage IB were enrolled in this study who had at least two of the following three intermediate risk factors (deep stromal invasion, lymphovascular space involvement, and large tumor size) after radical hysterectomy and all patients had no high risk factors and no radiotherapy. Of these patients, 22 patients had surgery only and 78 patients had cisplatin-based combination chemotherapy as adjuvant therapy postoperatively to improve survival. Kaplan-Meier survival curves and Cox's proportional-hazards regression model and log-rank test were used for survival analysis and to estimate the impact of prognostic factors on survival. RESULTS: The mean age was 52 years (range, 28 to 76 years). The overall survival rate of all intermediate tumors are 92% (92/100). Surgery only group is 81.8% (18/22) and adjuvant chemotherapy group is 94.9% (74/78). Comparison of survival between two groups revealed significant statistical difference in both univariant and multivariant survival analysis (P<0.05). The main toxicities of adjuvant chemotherapy were bone marrow suppression (18%), nausea and vomiting (5.2%) and alopecia in etoposide-cisplatin chemotherapy group (100%) but most side effects of postoperative adjuvant chemotherapy were transient, reversible and within acceptable limits to all patients. CONCLUSION: Cisplatin based combined adjuvant chemotherapy for intermediate risk tumors after radical hysterectomy is promising with significant improvement of overall survival and with acceptable toxicity profile.
Alopecia
;
Bone Marrow
;
Chemotherapy, Adjuvant
;
Cisplatin
;
Drug Therapy, Combination
;
Humans
;
Hysterectomy
;
Kaplan-Meier Estimate
;
Nausea
;
Retrospective Studies
;
Risk Factors
;
Survival Analysis
;
Survival Rate
;
Uterine Cervical Neoplasms
;
Vomiting
4.Application of 3D Surface Scanners in Forensic Science and Medicine ( I ): Digital Storage of Human Skeletons and Development of Appraisal Methods for Incident Scenes.
Nak Eun CHUNG ; Hyung Nam KOO ; Hyun Moo KANG ; Sang Seob LEE ; Hye Jin PARK ; Hyung Joong KIM ; Kyung Rak LEE ; Ik Jo CHUNG ; Dae Yeol KIM ; Dal Won KIM ; Sang Beom LIM ; Saebomi LEE ; Han Soo HAN ; Jung LEE ; Jun Suk KIM ; Ki Woong MOON ; Byong Hyun KIM ; Kyun Woo CHO ; Jin Pyeo KIM ; Yeo Soo KIM ; Sung Ho KIM ; In Soo SEO ; Dae Kyun PARK ; Jae Kwang CHUNG ; Yi Suk KIM ; Seong Kyu CHOI ; U Young LEE ; Hoon LEE ; Chae Keun KIM ; In Soo LEE ; Hoon KANG ; Won Seob KIM ; Dong Kyu KIM ; Dong Soo KIM ; Hyeong Jin CHOI ; Dong Il PARK ; Hong Soon CHOI ; Si Ro KIM ; Yong Seok HEO
Korean Journal of Legal Medicine 2012;36(1):85-96
The aim of this project was to use 3D scanning data collected at incident scenes and various evidence to 1) develop surveying methods based on 3D data consisting of overall and detailed scene evidence, captured by long-range and micros-canner, which can be shared by personnel working in different fields such as forensic medicine, video analysis, physical analysis, traffic engineering, and fire investigation; 2) create digital storage for human skeletons and set the foundation for virtual anthropology; and 3) improve the credibility of 3D evidence by virtual remodeling and simulation of incident scenes and evidence to provide a basis for advanced and high-tech scientific investigation. Two complete skeletons of male and female were scanned using 3D micro-scanner. Each bone was successfully reproduced and assembled in virtual space. In addition, recreating evidence scheduled for invasive examination by creating RP (rapid prototype) was possible. These outcomes could play an important role in setting up the new field of virtual anthropology. Case-specific surveying methods were developed through analysis of 3D scanning data collected by long-range surface scanners at the scenes of vehicular accidents, falls, shootings, and violent crimes. A technique and recording method was also developed for detecting forged seals by micro-scanning the pressure exerted on the seal. Appraisal methods developed in this project could be utilized to secure 3D data of human skeletal remains and incident scenes, create a standard for application, and increase objectivity, reproducibility, and accuracy of scanning methods. We plan to develop case-specific 3D data analysis techniques to improve the credibility of analysis at the NFS and to establish a 3D data collection and analysis team.
Crime
;
Data Collection
;
Female
;
Fires
;
Forensic Medicine
;
Forensic Sciences
;
Humans
;
Male
;
Skeleton
;
Statistics as Topic
5.Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer.
Won Deok JOO ; Ji Young LEE ; Jong Hyeok KIM ; Hang Jo YOO ; Hyun Jin ROH ; Jeong Yeol PARK ; Dae Yeon KIM ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM
Journal of Gynecologic Oncology 2009;20(2):96-100
OBJECTIVE: To evaluate the efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay (EDRA) in patients with epithelial ovarian cancer. METHODS: Thirty-nine patients were enrolled, who were diagnosed as epithelial ovarian cancer, tubal cancer or primary peritoneal carcinoma and received both debulking surgery and EDRA in Asan Medical Center between August 2004 and August 2006. Another thirty-nine patients were enrolled, who did not receive EDRA as control. Paclitaxel 175 mg/m2 and carboplatin AUC 5 were administered as primary combination chemotherapy to both EDRA group and the control group. In the EDRA group, paclitaxel was replaced by docetaxel 75 mg/m2 if a patient showed extreme drug resistance (EDR) to paclitaxel and not to docetaxel. Carboplatin was replaced by cisplatin 75 mg/m2 if a patient showed EDR to carboplatin and not to cisplatin. If only one drug showed low drug resistance (LDR), it was allowed to add another drug which showed LDR such as gemcitabine 1,000 mg/m2. CT scan was performed every three cycles and CA-125 was checked at each cycle. RESULTS: There was no significant difference in overall response rate between EDRA group and the control group (84.5% vs. 71.8%, p=0.107). However, 93.8% of patients in EDRA group did not show EDR to at least one drug and its response rate was significantly higher than that of the control group (93.3% vs. 71.8%, p=0.023). CONCLUSION: we could choose a combination of taxane and platinum which did not show EDR and could obtain a good response in the patients with ovarian cancer.
Area Under Curve
;
Biological Assay
;
Bridged Compounds
;
Carboplatin
;
Cisplatin
;
Deoxycytidine
;
Drug Resistance
;
Drug Therapy, Combination
;
Humans
;
Neoplasms, Glandular and Epithelial
;
Ovarian Neoplasms
;
Paclitaxel
;
Platinum
;
Taxoids
6.Clinical features and prognostic factors in Korean patients hospitalized for coronary artery disease (Catholic Heart Care Network Study).
Jin Man CHO ; Chong Jin KIM ; Woo Seung SHIN ; Eun Ju CHO ; Chul Soo PARK ; Pum Joon KIM ; Jong Min LEE ; Sang Hyun IHM ; Hyou Young RHIM ; Kiyuk CHANG ; Keon Woong MOON ; Yong Ju KIM ; Hae Ok JUNG ; Hee Yeol KIM ; Ji Won PARK ; Seung Won JIN ; Hui Kyung JEON ; Yong Seog OH ; Ki Dong YOO ; Doo Soo JEON ; Sang Hong BAEK ; Gil Whan LEE ; Ho Joong YOUN ; Man Young LEE ; Wook Sung CHUNG ; Jun Chul PARK ; Ki Bae SEUNG ; Tai Ho RHO ; Chul Min KIM ; In Soo PARK ; Jang Seong CHAE ; Jae Hyung KIM ; Kyu Bo CHOI ; Soon Jo HONG
Korean Journal of Medicine 2007;73(2):142-150
BACKGROUND: Coronary artery disease (CAD) has recently become one of the major causes of mortality and morbidity in Korea. However, not much epidemiologic and demographic data has yet been reported. The purpose of this study was to investigate the clinical features as well as the prognostic factors of patients with CAD. METHODS: We prospectively enrolled 1,665 consecutive patients with CAD who had been admitted to the Catholic University Hospitals from December 1999 to April 2003. RESULTS: Acute myocardial infarction (AMI) was the most common cause of admission (n=715, 42.9%). Dyslipidemia, hypertension and smoking were the most common risk factors. More than 70% of the patients who underwent percutaneous coronary intervention (PCI) received stent implantation. A total of 965 (612 males) patients were followed at least for 6 months (the mean follow-up duration was 23.8+/-12.2 months). The incidence rates of major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, target vessel revascularization) and cardiac death were 15.1% (n=146) and 2.2% (n=21), respectively. There was no difference in overall survival between the patients treated with medical therapy and those treated with PCI. By Cox regression analysis, the independent prognostic factors for MACE were PCI (95% CI: 1.75-4.85; p<0.01) and multivessel disease (95% CI: 1.03-2.04; p<0.05), and the independent prognostic factors for cardiac death were medical therapy (95% CI: 1.08-14.41; p<0.05) and old age (95% CI: 1.13-16.13; p<0.05). CONCLUSIONS: There was no difference in overall survival between the patients treated with medical therapy and those treated with PCI. However, PCI was superior to medical therapy for preventing death of the patients with acute coronary syndrome.
Acute Coronary Syndrome
;
Coronary Artery Disease*
;
Coronary Disease
;
Coronary Vessels*
;
Death
;
Dyslipidemias
;
Follow-Up Studies
;
Heart*
;
Hospitals, University
;
Humans
;
Hypertension
;
Incidence
;
Korea
;
Mortality
;
Myocardial Infarction
;
Percutaneous Coronary Intervention
;
Prognosis
;
Prospective Studies
;
Risk Factors
;
Smoke
;
Smoking
;
Stents
7.FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype.
Sang Ho KIM ; Yeo Kyeoung KIM ; Il Kwon LEE ; Deog Yeon JO ; Jong Ho WON ; Jae Yong KWAK ; Chang Yeol YIM ; Moo Rim PARK ; Deok Hwan YANG ; Sang Hee CHO ; Je Jung LEE ; Ik Joo CHUNG ; Hyeoung Joon KIM
Korean Journal of Hematology 2007;42(3):250-257
BACKGROUND: The presence of FLT3 internal tandem dupulication (FLT3/ITD) in patients with acute myeloid leukemia (AML) with normal karyotype was investigated in order to evaluate its clinical and prognostic significance. METHODS: The FLT3/ITD was studied by PCR assay in bone marrow samples obtained from 123 patients at diagnosis. Ninety patients who received intensive induction chemotherapy were evaluated. RESULTS: Of total 123 patients, forty-seven (38.2%) demonstrated the aberrant FLT3/ITD. Patients with FLT3/ITD had significantly higher leukocyte counts at presentation than did patients without FLT3/ITD (P=0.04). By multivariate analysis, the FLT3/ITD was an independent prognostic factor of leukemic-free survival (LFS) (P=0.01) in AML patients with normal karyotype. CONCLUSION: This study demonstrated that the presence of the FLT3/ITD was a significant factor for poor prognosis in AML patients with normal karyotype.
Bone Marrow
;
Diagnosis
;
Humans
;
Induction Chemotherapy
;
Karyotype*
;
Leukemia, Myeloid, Acute*
;
Leukocyte Count
;
Multivariate Analysis
;
Polymerase Chain Reaction
;
Prognosis
8.Correlation between Wound Dehescence after Major Urologic Surgery and MRSA Infection.
Jung Man KIM ; Sang Don LEE ; Won Yeol JO
Korean Journal of Urology 2006;47(3):298-302
PURPOSE: Postoperative wound infection accounts for approximately 15% of all hospital infections. Methicillin-resistant Staphylococcus aureus (MRSA) infections are 14% of the domestic hospital infections and this is increasing in incidence over time. The aim of this study was to retrospectively evaluate the relationship between wound dehescence after urologic surgery and MRSA infection. MATERIALS AND METHODS: Thirty patients (25 males and 5 females) who experienced wound dehescence after urologic surgery were subdivided into two separate groups; the MRSA group and non-MRSA group, and they were retrospectively analyzed via a chart review according to the age of the patients, the associated disease, the hepatic or renal functional status, the admission duration, the use of preoperative antibiotics and the number and duration of inserted catheters. RESULTS: The mean age of the MRSA group and the non-MRSA group was 62.6+/-12.4 years and 59.3+/-19.9 years, respectively (p=0.235). The elapsed operative time in the MRSA group and non-MRSA group was 355.8+/-99.5 minutes and 305.8+/-90.2 minutes, respectively (p=0.021). Contrary to 35.2+/-23.6 days of catheter duration in the MRSA group, that of the non-MRSA group was 14.6+/-8.5 days (p=0.007). The tendency for MRSA infection was observed for an increased duration of drain placement, a decreased hepatic or renal function and the preoperative antibiotic use. The extent of admission was obviously longer for the MRSA group (39.6+/-23.5 days) than for the non-MRSA group (28.9+/-9.9 days) (p=0.013). CONCLUSIONS: Wound dehescence assocated with MRSA infection is intimately related to the elapsed operative time and the period of catheter-insertion, which in turn increases the number of admission days.
Anti-Bacterial Agents
;
Catheters
;
Cross Infection
;
Humans
;
Incidence
;
Male
;
Methicillin Resistance
;
Methicillin-Resistant Staphylococcus aureus*
;
Operative Time
;
Retrospective Studies
;
Staphylococcus aureus
;
Surgical Wound Infection
;
Wound Infection
;
Wounds and Injuries*
9.Two Cases of Bronchiolitis Obliterans Organizing Pneumonia treated with Steroid and Cyclosporine therapy.
Jong Hoo LEE ; Myung Jae PARK ; Yi Hyung KIM ; Byung Jo PARK ; Won Taek OH ; Myung Yeol LEE ; Hong Mo KANG ; Jee Hong YOO
Tuberculosis and Respiratory Diseases 2005;59(3):315-320
A rapid response to corticosteroid treatment and a generally favourable outcome are characteristic features of BOOP (Bronchiolitis obliterans organizing pneumonia). However, with increasing experience of the clinical spectrum of this disease, it is now recognized that some patients are refractory to steroid, which is associated with a poor prognosis. Here, two cases of BOOP initially treated with predinisone and antibiotics without effects, but subsequently responded to secondary cyclosporine treatment, are reported.
Anti-Bacterial Agents
;
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
;
Cyclosporine*
;
Humans
;
Prognosis
10.A Case of Portal Vein Thrombosis Associated with Acute Pancreatitis and Cholangitis.
Dae Young CHEUNG ; Jae Kwang KIM ; Don Hyoun JO ; Hyun Jong OH ; Tae Ho KIM ; So Yeon LEE ; Soo Heon PARK ; Joon Yeol HAN ; Kyu Won CHUNG ; Hee Sik SUN
The Korean Journal of Gastroenterology 2005;46(1):60-65
Portal vein thrombosis is a rare complication accompanied with acute pancreatitis or cholangitis/cholecystitis. The main pathogenesis of portal vein thrombosis in pancreatitis or cholangitis/cholecystitis are suggested to be venous compression by pseudocyst and an imbalance between the blood coagulation and fibrinolysis. In this case report, we experienced a 63 year old male who developed portal vein thrombosis later in the course of the treatment of acute gallstone pancreatitis with cholangitis/cholecystitis without any symptom or sign. The diagnosis of portal vein thrombosis was given on follow up CT scan and serum protein S activity was decreased to 27% in laboratory study. Immediate anticoagulation therapy with heparin and thrombolytic therapy with urokinase and balloon dilatation were performed. Despite the aggressive treatment, complete reperfusion could not be obtained. With oral warfarin anticoagulation, the patient showed no disease progression and was discharged. We report a case of portal vein thrombosis as a complication of acute pancreatitis and cholangitis/cholecystitis with a review of literatures.
Acute Disease
;
Cholangitis/*complications/diagnosis
;
Cholecystitis/complications
;
Humans
;
Male
;
Middle Aged
;
Pancreatitis/*complications/diagnosis
;
*Portal Vein
;
Tomography, X-Ray Computed
;
Venous Thrombosis/diagnosis/*etiology

Result Analysis
Print
Save
E-mail